Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 3, 2010, Pages 311-318

  Thunberg, S ^a   Gafvelin, Guro ^a   Nord, M ^a   Gronneberg R ^a   Grunewald, J ^a   Eklund, A ^a   Van Hage, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allergy; Asthma; Bronchoalveolar lavage; FOXP3; Treg

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; NEUTRALIZING ANTIBODY; POLLEN ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; ASTHMA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG LAVAGE; LYMPHOCYTE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; TH2 CELL;

ADULT; ALLERGENS; ASTHMA; BETULA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CELL SEPARATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, SEASONAL; TH2 CELLS; YOUNG ADULT;

EID: 76249120530     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02218.x     Document Type: Article

References (36)

1. Corry DB. Emerging immune targets for the therapy of allergic asthma. Nat Rev Drug Discov 2002 1 : 55 64.
2. Cousins DJ, McDonald J, Lee TH. Therapeutic approaches for control of transcription factors in allergic disease. J Allergy Clin Immunol 2008 121 : 803 809.
3. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007 13 : 108 116.
4. Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R et al. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25 + regulatory thymocytes because of their responsiveness to different cytokines. Blood 2004 103 : 3117 3121.
5. Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, Ruckert B et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007 5 : e329.
6. Thunberg S, Akdis M, Akdis CA, Gronneberg R, Malmstrom V, Trollmo C et al. Immune regulation by CD4+ CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls. Clin Exp Allergy 2007 37 : 1127 1136.
7. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J et al. Relation of CD4+ CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004 363 : 608 615.
8. Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004 34 : 1364 1372.
9. Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ et al. Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007 119 : 1258 1266.
10. Dahlen B, Zetterstrom O, Bjorck T, Dahlen SE. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. Eur Respir J 1994 7 : 324 331.
11. Eklund A, Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax 1986 41 : 629 634.
12. Velickovic TC, Thunberg S, Polovic N, Neimert-Andersson T, Gronlund H, van Hage M et al. Low levels of endotoxin enhance allergen-stimulated proliferation and reduce the threshold for activation in human peripheral blood cells. Int Arch Allergy Immunol 2008 146 : 1 10.
13. Burgler S, Ouaked N, Bassin C, Basinski TM, Mantel PY, Siegmund K et al. Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol 2009 123 : 588 595, 595 e1-7.
14. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007 8 : 950 957.
15. Morgan AJ, Symon FA, Berry MA, Pavord ID, Corrigan CJ, Wardlaw AJ. IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. J Allergy Clin Immunol 2005 116 : 594 600.
16. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006 354 : 1117 1129.
17. Vijayanand P, Seumois G, Pickard C, Powell RM, Angco G, Sammut D et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007 356 : 1410 1422.
18. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+ CD25- T cells. J Clin Invest 2003 112 : 1437 1443.
19. Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, Ling KL et al. Analysis of FOXP3 protein expression in human CD4+ CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005 35 : 1681 1691.
20. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007 19 : 345 354.
21. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4 + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007 110 : 2983 2990.
22. Pillai V, Ortega SB, Wang CK, Karandikar NJ. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007 123 : 18 29.
23. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006 203 : 1701 1711.
24. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006 203 : 1693 1700.
25. Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007 148 : 53 63.
26. Ebner C, Schenk S, Najafian N, Siemann U, Steiner R, Fischer GW et al. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995 154 : 1932 1940.
27. Bullens DM, Van Den Keybus C, Dilissen E, Kasran A, Ceuppens JL. Allergen-specific T cells from birch-pollen-allergic patients and healthy controls differ in T helper 2 cytokine and in interleukin-10 production. Clin Exp Allergy 2004 34 : 879 887.
28. Van Overtvelt L, Wambre E, Maillere B, von Hofe E, Louise A, Balazuc AM et al. Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol 2008 180 : 4514 4522.
29. Stassen M, Jonuleit H, Muller C, Klein M, Richter C, Bopp T et al. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 2004 173 : 267 274.
30. Lin YL, Shieh CC, Wang JY. The functional insufficiency of human CD4 + CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation. Allergy 2008 63 : 67 74.
31. Johansson MW, Kelly EA, Busse WW, Jarjour NN, Mosher DF. Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge. J Immunol 2008 180 : 7622 7635.
32. Teran LM, Carroll MP, Shute JK, Holgate ST. Interleukin 5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment. Cytokine 1999 11 : 518 522.
33. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008 9 : 1341 1346.
34. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008 9 : 1347 1355.
35. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 2000 105 (1 Pt 1 108 115.
36. Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 2003 111 : 1319 1327.